id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-E-0662-0001,FDA,FDA-2010-E-0662,Aventis Pharma S.A. - Patent Term Extension Application,Other,APP-Application,2010-12-30T05:00:00Z,2010,12,2010-12-30T05:00:00Z,,2013-07-27T23:41:23Z,,0,0,0900006480bc2a98
FDA-2010-E-0656-0001,FDA,FDA-2010-E-0656,Amgen Inc. - Patent Term Extension Application,Other,APP-Application,2010-12-30T05:00:00Z,2010,12,2010-12-30T05:00:00Z,,2013-08-11T04:43:36Z,,0,0,0900006480bc285b
FDA-2010-E-0656-0003,FDA,FDA-2010-E-0656,U.S. Patent and Trademark Office to FDA - Letter,Other,LET-Letter,2010-12-30T05:00:00Z,2010,12,2010-12-30T05:00:00Z,,2010-12-30T16:57:57Z,,0,0,0900006480bc28a7
FDA-2010-E-0659-0001,FDA,FDA-2010-E-0659,Amgen Inc. - Patent Term Extension Application,Other,APP-Application,2010-12-30T05:00:00Z,2010,12,2010-12-30T05:00:00Z,,2013-07-27T23:41:21Z,,0,0,0900006480bc28b0
FDA-2010-E-0662-0002,FDA,FDA-2010-E-0662,U.S. Patent and Trademark Office to FDA - Letter,Other,LET-Letter,2010-12-30T05:00:00Z,2010,12,2010-12-30T05:00:00Z,,2013-08-11T01:39:02Z,,0,0,0900006480bc2a9a
FDA-2010-E-0661-0002,FDA,FDA-2010-E-0661,U.S. Patent and Trademark Office to FDA - Letter,Other,LET-Letter,2010-12-30T05:00:00Z,2010,12,2010-12-30T05:00:00Z,,2013-07-27T23:41:23Z,,0,0,0900006480bc2a28
FDA-2010-E-0656-0002,FDA,FDA-2010-E-0656,U.S. Patent and Trademark Office to FDA - Letter,Other,LET-Letter,2010-12-30T05:00:00Z,2010,12,2010-12-30T05:00:00Z,,2013-07-27T23:41:21Z,,0,0,0900006480bc285c
FDA-2010-E-0657-0002,FDA,FDA-2010-E-0657,U.S. Patent and Trademark Office to FDA - Letter,Other,LET-Letter,2010-12-30T05:00:00Z,2010,12,2010-12-30T05:00:00Z,,2010-12-30T18:00:32Z,,0,0,0900006480bc28ab
FDA-2010-E-0657-0001,FDA,FDA-2010-E-0657,Amgen Inc. - Patent Term Extension Application,Other,APP-Application,2010-12-30T05:00:00Z,2010,12,2010-12-30T05:00:00Z,,2013-08-11T01:39:02Z,,0,0,0900006480bc28a9
FDA-2010-E-0657-0003,FDA,FDA-2010-E-0657,U.S. Patent and Trademark Office to FDA - Letter,Other,LET-Letter,2010-12-30T05:00:00Z,2010,12,2010-12-30T05:00:00Z,,2010-12-30T18:00:33Z,,0,0,0900006480bc28ae
FDA-2010-E-0659-0003,FDA,FDA-2010-E-0659,U.S. Patent and Trademark Office to FDA - Letter,Other,LET-Letter,2010-12-30T05:00:00Z,2010,12,2010-12-30T05:00:00Z,,2013-07-27T23:41:22Z,,0,0,0900006480bc29ce
FDA-2010-E-0663-0002,FDA,FDA-2010-E-0663,U.S. Patent and Trademark Office to FDA - Letter,Other,LET-Letter,2010-12-30T05:00:00Z,2010,12,2010-12-30T05:00:00Z,,2013-08-11T04:43:37Z,,0,0,0900006480bc2a9e
FDA-2010-E-0663-0001,FDA,FDA-2010-E-0663,"Danek, et al. - Patent Term Extension Application",Other,APP-Application,2010-12-30T05:00:00Z,2010,12,2010-12-30T05:00:00Z,,2013-07-27T23:41:23Z,,0,0,0900006480bc2a9c
FDA-2010-E-0659-0002,FDA,FDA-2010-E-0659,U.S. Patent and Trademark Office to FDA - Letter,Other,LET-Letter,2010-12-30T05:00:00Z,2010,12,2010-12-30T05:00:00Z,,2013-07-27T23:41:22Z,,0,0,0900006480bc29cc
FDA-2010-E-0661-0001,FDA,FDA-2010-E-0661,Aventis Pharma S.A. - Patent Term Extension Application,Other,APP-Application,2010-12-30T05:00:00Z,2010,12,2010-12-30T05:00:00Z,,2013-07-27T23:41:23Z,,0,0,0900006480bc2a24
FDA-2010-E-0653-0001,FDA,FDA-2010-E-0653,"Gilead Sciences, Inc. - Patent Term Extension Application",Other,APP-Application,2010-12-29T05:00:00Z,2010,12,2010-12-29T05:00:00Z,,2013-07-27T23:41:14Z,,0,0,0900006480bc1ee3
FDA-2008-E-0266-0008,FDA,FDA-2008-E-0266,U.S. Patent and Trademark Office to Johnson & Johnson - Notice of Final Determination Letter,Other,LET-Letter,2010-12-29T05:00:00Z,2010,12,2010-12-29T05:00:00Z,,2013-07-27T23:41:14Z,,0,0,0900006480bc1ecf
FDA-2010-E-0653-0002,FDA,FDA-2010-E-0653,U.S. Patent and Trademark Office to FDA - Letter,Other,LET-Letter,2010-12-29T05:00:00Z,2010,12,2010-12-29T05:00:00Z,,2013-07-27T23:41:14Z,,0,0,0900006480bc1ee5
FDA-2010-E-0654-0002,FDA,FDA-2010-E-0654,U.S Patent and Trademark Office to FDA - Letter,Other,LET-Letter,2010-12-29T05:00:00Z,2010,12,2010-12-29T05:00:00Z,,2013-07-27T23:41:17Z,,0,0,0900006480bc2342
FDA-2010-E-0655-0002,FDA,FDA-2010-E-0655,U.S Patent and Trademark Office to FDA - Letter,Other,LET-Letter,2010-12-29T05:00:00Z,2010,12,2010-12-29T05:00:00Z,,2013-07-27T23:41:17Z,,0,0,0900006480bc2344
FDA-1997-N-0020-0014,FDA,FDA-1997-N-0020,"FDA/CFSAN to the Division of Dockets Management, February 6, 2006",Other,Memorandum,2010-12-29T05:00:00Z,2010,12,2010-12-29T05:00:00Z,,2011-10-26T21:51:50Z,,0,0,0900006480bc0beb
FDA-1978-N-0021-0032,FDA,FDA-1978-N-0021,"Letter from FDA/CDER to Peter S. Reichertz, Esq. and Christopher A. Brown, Esq.",Other,LET-Letter,2010-12-29T05:00:00Z,2010,12,2010-12-29T05:00:00Z,,2016-09-13T15:18:53Z,,0,0,0900006480bc2181
FDA-2010-E-0654-0001,FDA,FDA-2010-E-0654,"Gilead Sciences, Inc. - Patent Term Extension Application",Other,APP-Application,2010-12-29T05:00:00Z,2010,12,2010-12-29T05:00:00Z,,2013-07-27T23:41:17Z,,0,0,0900006480bc225b
FDA-2010-E-0655-0001,FDA,FDA-2010-E-0655,"Gilead Sciences, Inc. - Patent Term Extension Application",Other,APP-Application,2010-12-29T05:00:00Z,2010,12,2010-12-29T05:00:00Z,,2013-08-11T03:12:28Z,,0,0,0900006480bc2343
FDA-2010-N-0511-0003,FDA,FDA-2010-N-0511,FDA/DDM Letter to Division of Wyeth Holdings - Letter,Other,LET-Letter,2010-12-29T05:00:00Z,2010,12,2010-12-29T05:00:00Z,,2010-12-29T14:34:06Z,,0,0,0900006480bc1b46
FDA-2008-E-0261-0008,FDA,FDA-2008-E-0261,U.S. Patent and Trademark Office to Nixon Peabody LLP - Notice of Final Determination,Other,LET-Letter,2010-12-28T05:00:00Z,2010,12,2010-12-28T05:00:00Z,,2013-07-27T23:40:43Z,,0,0,0900006480bc0e70
FDA-2009-E-0014-0007,FDA,FDA-2009-E-0014,U.S. Patent & Trademark Office to Abbott Diabetes Care Inc. - Letter with enclosure,Other,LET-Letter,2010-12-28T05:00:00Z,2010,12,2010-12-28T05:00:00Z,,2013-07-27T23:40:43Z,,0,0,0900006480bc0e15
FDA-2008-E-0258-0008,FDA,FDA-2008-E-0258,U.S. Patent and Trademark Office to Nixon Peabody LLP - Notice of Final Determination,Other,LET-Letter,2010-12-28T05:00:00Z,2010,12,2010-12-28T05:00:00Z,,2013-07-27T23:40:43Z,,0,0,0900006480bc0e6e
FDA-2008-E-0260-0008,FDA,FDA-2008-E-0260,U.S. Patent and Trademark Office to Nixon Peabody LLP - Notice of Final Determination,Other,LET-Letter,2010-12-28T05:00:00Z,2010,12,2010-12-28T05:00:00Z,,2013-08-11T03:12:26Z,,0,0,0900006480bc0e72
FDA-2010-N-0002-0089,FDA,FDA-2010-N-0002,Freedom of Information Summary - [NADA-141-319] - Deslorelin acetate Injection Horses/Estrous mares,Other,FOIS-Freedom of Information Summary (No Federal Register Publication),2010-12-28T05:00:00Z,2010,12,2010-12-28T05:00:00Z,,2010-12-28T16:01:31Z,,0,0,0900006480bc13dc
FDA-2010-N-0511-0002,FDA,FDA-2010-N-0511,FDA/DDM Letter to Division of Wyeth Holdings - Letter,Other,,2010-12-28T00:00:00Z,2010,12,,,2010-12-29T14:18:57Z,,0,1,0900006480b77e4c
FDA-2010-P-0630-0009,FDA,FDA-2010-P-0630,"Acknowledgement Letter to Heyltex Corporation, HEYL Chemisch-Pharmazeutische Fabrik GmbH & Co. KG - Correction",Other,Correction(s),2010-12-27T05:00:00Z,2010,12,2010-12-27T05:00:00Z,,2012-05-09T22:38:35Z,,0,0,0900006480bbd326
FDA-2010-E-0037-0007,FDA,FDA-2010-E-0037,U.S. Patent & Trademark Office to FDA/CDER - Letter with enclosure,Other,LET-Letter,2010-12-27T05:00:00Z,2010,12,2010-12-27T05:00:00Z,,2013-07-27T23:40:38Z,,0,0,0900006480bc087d
FDA-2009-E-0020-0009,FDA,FDA-2009-E-0020,"U.S. Patent & Trademark Office to  Millen, White, Zelano & Branigan, P.C. - Notice of Final Determinaton",Other,LET-Letter,2010-12-27T05:00:00Z,2010,12,2010-12-27T05:00:00Z,,2013-08-11T03:12:25Z,,0,0,0900006480bc0880
FDA-2004-E-0266-0009,FDA,FDA-2004-E-0266,U.S. Patent & Trademark Office to  Connolly Bove Lodge & Hutz LLP - Notice of Final Determinaton,Other,LET-Letter,2010-12-27T05:00:00Z,2010,12,2010-12-27T05:00:00Z,,2013-07-27T23:40:38Z,,0,0,0900006480bc087f
FDA-2010-P-0582-0005,FDA,FDA-2010-P-0582,"Acknowledgement Letter to Lachman Consultant Services, Inc.",Other,ACK-Acknowledgement Letter,2010-12-27T05:00:00Z,2010,12,2010-12-27T05:00:00Z,,2013-07-27T23:37:21Z,,0,0,0900006480b8a212
FDA-2007-E-0048-0008,FDA,FDA-2007-E-0048,"U.S. Patent & Trademark Office to Harness, Dickey & Pierce, PLC  - Notice of Final Determinaton",Other,LET-Letter,2010-12-27T05:00:00Z,2010,12,2010-12-27T05:00:00Z,,2013-08-11T01:38:57Z,,0,0,0900006480bc0881
FDA-2010-V-0587-0002,FDA,FDA-2010-V-0587,Acknowledgement Letter to Syndicate Hospitality Group,Other,ACK-Acknowledgement Letter,2010-12-27T05:00:00Z,2010,12,2010-12-27T05:00:00Z,,2013-07-27T23:37:31Z,,0,0,0900006480b93263
FDA-2010-V-0587-0001,FDA,FDA-2010-V-0587,Syndicate Hospitality Group - Application for Variance,Other,VAR-Application for Variance,2010-12-27T05:00:00Z,2010,12,2010-12-27T05:00:00Z,,2013-07-27T23:37:31Z,,0,0,0900006480b9321a
FDA-2010-P-0582-0001,FDA,FDA-2010-P-0582,"Lachman Consultant Services, Inc. - Citizen Petition",Other,CP-Citizen Petition,2010-12-27T05:00:00Z,2010,12,2010-12-27T05:00:00Z,,2024-11-12T04:55:42Z,,1,0,0900006480b88126
FDA-2007-E-0104-0008,FDA,FDA-2007-E-0104,USPTO to FDA/CDER - Letter,Other,LET-Letter,2010-12-27T05:00:00Z,2010,12,2010-12-27T05:00:00Z,,2013-07-27T23:40:38Z,,0,0,0900006480bc0864
FDA-2007-E-0482-0006,FDA,FDA-2007-E-0482,USPT to FDA/CDER - Letter,Other,LET-Letter,2010-12-23T05:00:00Z,2010,12,,,2010-12-27T18:17:53Z,,0,0,0900006480bbe90f
FDA-2004-E-0270-0009,FDA,FDA-2004-E-0270,Notice of Determination and Requirement for Election,Other,LET-Letter,2010-12-23T05:00:00Z,2010,12,,,2010-12-27T17:55:37Z,,0,0,0900006480bbec80
FDA-2010-D-0575-0002,FDA,FDA-2010-D-0575,Guidance for FDA Staff Compliance Policy Guide Sec. 510.80 Beverages - Serving Size Labeling,Other,GDL-Guidance (Supporting and Related Materials),2010-12-23T05:00:00Z,2010,12,2010-12-23T05:00:00Z,2011-02-23T04:59:59Z,2010-12-23T14:47:35Z,,0,0,0900006480bbe8dc
FDA-2009-D-0466-0009,FDA,FDA-2009-D-0466,Guidance for FDA Staff; Compliance Policy Guide Sec. 527.300 Dairy Products - Microbial Contaminants and Alkaline Phophatase Activity,Other,Guidance,2010-12-23T05:00:00Z,2010,12,2010-12-23T05:00:00Z,,2024-11-07T22:26:34Z,,1,0,0900006480bbe8e0
FDA-2010-E-0037-0006,FDA,FDA-2010-E-0037,FDA/CDER to U.S. Patent & Trademark Office - Letter,Other,LET-Letter,2010-12-23T05:00:00Z,2010,12,2010-12-23T05:00:00Z,,2010-12-23T15:48:11Z,,0,0,0900006480bbeaf5
FDA-2008-E-0307-0008,FDA,FDA-2008-E-0307,Noice of Determination - Letter,Other,LET-Letter,2010-12-23T05:00:00Z,2010,12,,,2010-12-27T18:02:38Z,,0,0,0900006480bbeaf0
FDA-2010-P-0628-0003,FDA,FDA-2010-P-0628,"Acknowledgement Letter to Heyltex Corporation, Heyl Chemisch-Pharmazeutische Fabrik GnbH & Co. KG - Correction",Other,CR-Correction,2010-12-22T05:00:00Z,2010,12,2010-12-22T05:00:00Z,,2013-07-27T23:40:14Z,,0,0,0900006480bbd27f
FDA-2007-E-0104-0007,FDA,FDA-2007-E-0104,USPTO to FDA/CDER - Letter,Other,LET-Letter,2010-12-22T05:00:00Z,2010,12,,,2010-12-27T18:48:10Z,,0,0,0900006480bbd154
FDA-2008-E-0102-0003,FDA,FDA-2008-E-0102,USPTO to FDA/CDER - Letter,Other,LET-Letter,2010-12-22T05:00:00Z,2010,12,,,2010-12-27T18:20:09Z,,0,0,0900006480bbd1eb
FDA-2010-P-0559-0004,FDA,FDA-2010-P-0559,Change in Classification Petition from Saliwell Ltd.,Other,Change in Classification Petition,2010-12-22T05:00:00Z,2010,12,2010-12-22T05:00:00Z,,2015-03-01T00:42:19Z,,0,0,0900006480b78471
FDA-2010-P-0559-0007,FDA,FDA-2010-P-0559,Acknowledgement Letter to Saliwell Ltd.,Other,ACK-Acknowledgement Letter,2010-12-22T05:00:00Z,2010,12,2010-12-22T05:00:00Z,,2013-07-27T23:40:25Z,,0,0,0900006480bbe1dd
FDA-2008-E-0315-0003,FDA,FDA-2008-E-0315,USPTO to FDA/CDER - Letter,Other,LET-Letter,2010-12-22T05:00:00Z,2010,12,2010-12-22T05:00:00Z,,2010-12-22T15:54:05Z,,0,0,0900006480bbd24a
FDA-2010-P-0580-0003,FDA,FDA-2010-P-0580,"Acknowledgement Letter to Bracewell & Giuliani, LLP",Other,ACK-Acknowledgement Letter,2010-12-21T05:00:00Z,2010,12,2010-12-21T05:00:00Z,,2013-08-11T04:42:55Z,,0,0,0900006480b8a278
FDA-2010-P-0580-0001,FDA,FDA-2010-P-0580,"Bracewell & Giuliani, LLP - Citizen Petition",Other,CP-Citizen Petition,2010-12-21T05:00:00Z,2010,12,2010-12-21T05:00:00Z,,2024-11-12T04:54:58Z,,1,0,0900006480b8a152
FDA-2007-E-0226-0003,FDA,FDA-2007-E-0226,USPTO to FDA/CDER,Other,LET-Letter,2010-12-21T05:00:00Z,2010,12,,,2010-12-27T18:52:44Z,,0,0,0900006480bbad42
FDA-2008-E-0092-0008,FDA,FDA-2008-E-0092,USPTO to FDA/CDER - Letter,Other,LET-Letter,2010-12-21T05:00:00Z,2010,12,,,2010-12-27T18:50:57Z,,0,0,0900006480bbcf60
FDA-2003-V-0297-0006,FDA,FDA-2003-V-0297,"Lumalaser, Inc. - Amendment",Other,AMD-Amendment,2010-12-21T05:00:00Z,2010,12,2010-12-21T05:00:00Z,,2013-07-27T23:36:18Z,,0,0,0900006480b7d8d8
FDA-2010-V-0569-0002,FDA,FDA-2010-V-0569,Acknowledgement Letter to Sheffield Family Life Center,Other,ACK-Acknowledgement Letter,2010-12-21T05:00:00Z,2010,12,2010-12-21T05:00:00Z,,2013-08-11T04:42:46Z,,0,0,0900006480b7d8d7
FDA-2010-V-0569-0001,FDA,FDA-2010-V-0569,Sheffield Family Life Center - Application for Variance,Other,VAR-Application for Variance,2010-12-21T05:00:00Z,2010,12,2010-12-21T05:00:00Z,,2013-07-27T23:36:18Z,,0,0,0900006480b7d8d6
DOE-HQ-2010-0025-0002,DOE,DOE-HQ-2010-0025,Regulatory Plan - Fall 2010,Other,NA,2010-12-20T05:00:00Z,2010,12,2010-12-20T05:00:00Z,,2010-12-20T17:30:34Z,,0,0,0900006480bba9ce
DOE-HQ-2010-0025-0001,DOE,DOE-HQ-2010-0025,Semiannual Regulatory Agenda - Fall 2010,Other,NA,2010-12-20T05:00:00Z,2010,12,2010-12-20T05:00:00Z,,2010-12-20T17:30:34Z,,0,0,0900006480bba9cd
EPA-HQ-OA-2010-1069-0002,EPA,EPA-HQ-OA-2010-1069,Regulatory Plan - Fall 2010,Other,Significant Guidance,2010-12-20T05:00:00Z,2010,12,2010-12-20T05:00:00Z,,2010-12-20T17:30:36Z,,0,0,0900006480bbaa04
EPA-HQ-OA-2010-1069-0001,EPA,EPA-HQ-OA-2010-1069,Semiannual Regulatory Agenda - Fall 2010,Other,Significant Guidance,2010-12-20T05:00:00Z,2010,12,2010-12-20T05:00:00Z,,2010-12-20T17:30:36Z,,0,0,0900006480bba9ef
EPA-HQ-OW-2010-0728-0001,EPA,EPA-HQ-OW-2010-0728,Memorandum Opening Docket EPA-HQ-OW-2010-0728 for Public Access,Other,Memorandum to Open a Docket,2010-12-20T05:00:00Z,2010,12,2010-12-20T05:00:00Z,2011-02-22T04:59:59Z,2012-02-23T19:14:02Z,,0,0,0900006480b472cf
FDA-2010-P-0628-0001,FDA,FDA-2010-P-0628,"Heyltex Corporation, Heyl Chemisch-Pharmazeutische Fabrik GnbH & Co. KG - Citizen Petition",Other,CP-Citizen Petition,2010-12-20T05:00:00Z,2010,12,2010-12-20T05:00:00Z,,2013-07-27T23:39:14Z,,0,0,0900006480bb2bb2
FDA-2010-P-0638-0001,FDA,FDA-2010-P-0638,"Dinsmore & Shohl, LLP - Citizen Petition",Other,CP-Citizen Petition,2010-12-20T05:00:00Z,2010,12,2010-12-20T05:00:00Z,,2013-07-27T23:39:36Z,,0,0,0900006480bb641b
FDA-2008-E-0315-0004,FDA,FDA-2008-E-0315,US Patent & Trademark Office - Transmittal Form,Other,LET-Letter,2010-12-20T05:00:00Z,2010,12,,,2013-07-27T23:40:14Z,,0,0,0900006480bbd27d
FDA-2010-P-0624-0001,FDA,FDA-2010-P-0624,"Cubist Pharmaceuticals, Inc. - Citizen Petition",Other,CP-Citizen Petition,2010-12-20T05:00:00Z,2010,12,2010-12-20T05:00:00Z,,2013-08-11T03:12:04Z,,0,0,0900006480bb16be
FDA-2010-P-0630-0002,FDA,FDA-2010-P-0630,"Acknowledgement Letter to Heyltex Corporation, HEYL Chemisch-Pharmazeutische Fabrik GmbH & Co. KG",Other,Acknowledgement Letter/Receipt,2010-12-20T05:00:00Z,2010,12,2010-12-20T05:00:00Z,,2012-05-09T22:31:38Z,,0,0,0900006480bb3e0a
FDA-2010-P-0632-0001,FDA,FDA-2010-P-0632,"Acknowledgement Letter to Sandoz, Inc.",Other,ACK-Acknowledgement Letter,2010-12-20T05:00:00Z,2010,12,2010-12-20T05:00:00Z,,2011-06-13T21:16:33Z,,0,0,0900006480bb5126
FDA-2010-P-0624-0002,FDA,FDA-2010-P-0624,"Acknowledgement Letter to Cubist Pharmaceuticals, Inc.",Other,ACK-Acknowledgement Letter,2010-12-20T05:00:00Z,2010,12,2010-12-20T05:00:00Z,,2010-12-20T15:14:57Z,,0,0,0900006480bb16bf
FDA-2010-P-0628-0002,FDA,FDA-2010-P-0628,"Acknowledgement Letter to Heyltex Corporation, Heyl Chemisch-Pharmazeutische Fabrik GnbH & Co. KG",Other,Acknowledgement Letter/Receipt,2010-12-20T05:00:00Z,2010,12,2010-12-20T05:00:00Z,,2013-08-11T04:43:15Z,,0,0,0900006480bb32df
FDA-2010-P-0630-0001,FDA,FDA-2010-P-0630,"Heyltex Corporation, HEYL Chemisch-Pharmazeutische Fabrik GmbH & Co. KG - Citizen Petition",Other,Citizen Petition,2010-12-20T05:00:00Z,2010,12,2010-12-20T05:00:00Z,,2024-11-07T22:26:27Z,,1,0,0900006480bb3df1
FDA-2010-P-0638-0002,FDA,FDA-2010-P-0638,"Acknowledgement Letter to Dinsmore & Shohl, LLP",Other,ACK-Acknowledgement Letter,2010-12-20T05:00:00Z,2010,12,2010-12-20T05:00:00Z,,2013-08-11T03:12:11Z,,0,0,0900006480bb6422
SEC-2010-1963-0001,SEC,,Semiannual Regulatory Agenda - Fall 2010,Other,,2010-12-20T05:00:00Z,2010,12,2010-12-20T05:00:00Z,,2010-12-20T17:30:42Z,,0,0,0900006480bbaa8f
USDA-2010-0005-0001,USDA,USDA-2010-0005,Semiannual Regulatory Agenda - Fall 2010,Other,NA,2010-12-20T05:00:00Z,2010,12,2010-12-20T05:00:00Z,,2010-12-20T17:30:43Z,,0,0,0900006480bbaab4
USDA-2010-0005-0002,USDA,USDA-2010-0005,Regulatory Plan - Fall 2010,Other,NA,2010-12-20T05:00:00Z,2010,12,2010-12-20T05:00:00Z,,2010-12-20T17:30:43Z,,0,0,0900006480bbaab5
FDA-2010-P-0559-0001,FDA,FDA-2010-P-0559,Acknowledgement Letter to Saliwell Ltd.,Other,,2010-12-20T00:00:00Z,2010,12,,,2013-07-27T23:35:48Z,,0,1,0900006480b789bb
FDA-2010-P-0642-0001,FDA,FDA-2010-P-0642,"Teva Pharmaceutical Industries Ltd., Teva Neuroscience, Inc. - Citizen Petition",Other,CP-Citizen Petition,2010-12-17T05:00:00Z,2010,12,2010-12-17T05:00:00Z,,2011-06-16T12:40:15Z,,0,0,0900006480bb890d
FDA-2008-P-0421-0006,FDA,FDA-2008-P-0421,FDA/CDER to Buchanan Ingersoll & Rooney PC  - Peititon Denial,Other,PDN-Petition Denial,2010-12-17T05:00:00Z,2010,12,2010-12-17T05:00:00Z,,2013-07-27T23:39:59Z,,0,0,0900006480bb95a1
FDA-2010-P-0642-0002,FDA,FDA-2010-P-0642,"Acknowledgement Letter to Teva Pharmaceutical Industries Ltd., Teva Neuroscience, Inc.",Other,ACK-Acknowledgement Letter,2010-12-17T05:00:00Z,2010,12,2010-12-17T05:00:00Z,,2013-07-27T23:39:53Z,,0,0,0900006480bb890e
FDA-2007-P-0339-0004,FDA,FDA-2007-P-0339,"FDA/CDER to Anil K. Mandal, M.D. - Peititon Denial",Other,PDN-Petition Denial,2010-12-17T05:00:00Z,2010,12,2010-12-17T05:00:00Z,,2013-07-27T23:39:59Z,,0,0,0900006480bb95a0
APHIS-2007-0044-12532,APHIS,APHIS-2007-0044,Glyphosate-Tolerant Alfalfa Events:  Final Environmental Impact Statement (December 2010),Other,EIS,2010-12-16T05:00:00Z,2010,12,2010-12-16T05:00:00Z,2011-01-25T04:59:59Z,2011-01-05T16:11:55Z,,0,0,0900006480bb8007
EPA-R09-OAR-2010-1061-0001,EPA,EPA-R09-OAR-2010-1061,"Pacific Oroville Power Final PSD Permit Amendment Issued December 13, 2010",Other,NA,2010-12-16T05:00:00Z,2010,12,2010-12-16T05:00:00Z,,2011-01-27T11:43:12Z,,0,0,0900006480bb8a19
EPA-R09-OAR-2010-1062-0001,EPA,EPA-R09-OAR-2010-1062,"Knauf Insulation PSD Permit Amendment Issued December 13, 2010",Other,,2010-12-16T05:00:00Z,2010,12,2010-12-16T05:00:00Z,,2010-12-16T22:54:02Z,,0,0,0900006480bb8a1f
FDA-2010-N-0621-0001,FDA,FDA-2010-N-0621,"FDA/Center for Drug Evaluation and Research (CDER) to Genentech, Inc. - Letter",Other,Letter(s),2010-12-16T05:00:00Z,2010,12,2010-12-16T05:00:00Z,,2011-06-30T20:20:28Z,,0,0,0900006480bb81e7
FDA-2010-D-0605-0002,FDA,FDA-2010-D-0605,"Guidance for Industry; Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements Small Entiy Compliance Guide",Other,Guidance,2010-12-16T05:00:00Z,2010,12,2010-12-16T05:00:00Z,,2024-11-07T22:29:06Z,,1,0,0900006480bb8335
FDA-1987-P-0042-0003,FDA,FDA-1987-P-0042,FDA/CDER to Lyphomed Inc. - Petition Approval,Other,PAV-Petition Approval,2010-12-15T05:00:00Z,2010,12,2010-12-15T05:00:00Z,,2013-08-11T02:32:48Z,,0,0,090000648046c5da
FDA-1987-P-0042-0002,FDA,FDA-1987-P-0042,"Acknowledgement Letter to Lyphomed, Inc.",Other,ACK-Acknowledgement Letter,2010-12-15T05:00:00Z,2010,12,2010-12-15T05:00:00Z,,2013-07-27T23:39:36Z,,0,0,0900006480bb6400
FDA-2010-D-0616-0002,FDA,FDA-2010-D-0616,Codevelopment of Two or More Unmarketed Investigational Drugs for Use in Combination - Draft Guidance,Other,GDL-Guidance (Supporting and Related Materials),2010-12-15T05:00:00Z,2010,12,2010-12-15T05:00:00Z,,2019-10-21T13:19:49Z,,0,0,0900006480bb7e80
FDA-1987-P-0042-0001,FDA,FDA-1987-P-0042,"LyphoMed, Inc. - Citizen Petition",Other,CP-Citizen Petition,2010-12-15T05:00:00Z,2010,12,2010-12-15T05:00:00Z,,2013-07-27T20:47:08Z,,0,0,090000648046c5d9
FDA-2010-P-0172-0006,FDA,FDA-2010-P-0172,"FDA/CDER to Lachman Consultant Services, Inc. Response Letter",Other,LET-Letter,2010-12-14T05:00:00Z,2010,12,2010-12-14T05:00:00Z,,2013-08-11T03:12:10Z,,0,0,0900006480bb6372
FDA-2010-P-0359-0003,FDA,FDA-2010-P-0359,Goodwin Procter LLP - Letter,Other,LET-Letter,2010-12-14T05:00:00Z,2010,12,2010-12-14T05:00:00Z,,2010-12-14T18:57:46Z,,0,0,0900006480bb615d
FDA-2010-P-0263-0004,FDA,FDA-2010-P-0263,Interim Response to First Juice Inc.,Other,LET-Letter,2010-12-14T05:00:00Z,2010,12,2010-12-14T05:00:00Z,,2013-08-11T04:43:18Z,,0,0,0900006480bb636e
FDA-2006-P-0150-0005,FDA,FDA-2006-P-0150,"Citizen Petition Approval from FDA CDER to Lachman Consultant Services, Inc.",Other,Approval,2010-12-14T05:00:00Z,2010,12,2010-12-14T05:00:00Z,,2025-01-07T15:29:36Z,,0,0,0900006480bb6370
FDA-2010-P-0177-0005,FDA,FDA-2010-P-0177,"FDA/CDER to EAS Consulting Group, LLC - Response Letter",Other,LET-Letter,2010-12-14T05:00:00Z,2010,12,2010-12-14T05:00:00Z,,2013-08-11T01:38:43Z,,0,0,0900006480bb63c8
EPA-R09-OAR-2010-0226-0005,EPA,EPA-R09-OAR-2010-0226,Final Prevention of Significant Deterioration Permit of Sierra Pacific Industries - Loyalton Project (SAC 87-01-A),Other,,2010-12-10T05:00:00Z,2010,12,2010-12-10T05:00:00Z,,2010-12-10T20:16:30Z,,0,0,0900006480b4a471
FDA-2005-D-0072-0006,FDA,FDA-2005-D-0072,"Guidance for the Public, FDA Advisory Committee Members, and FDA Staff: The Open Public Hearing at FDA Advisory Committee Meeting; Final Guidance",Other,GDL-Guidance (Supporting and Related Materials),2010-12-10T05:00:00Z,2010,12,2010-12-10T05:00:00Z,,2010-12-11T00:41:54Z,,0,0,0900006480bb3e0d
FDA-2010-P-0619-0002,FDA,FDA-2010-P-0619,"Acknowledgement Letter to Richard F. Edlich, M.D., Ph.D.",Other,ACK-Acknowledgement Letter,2010-12-09T05:00:00Z,2010,12,2010-12-09T05:00:00Z,,2013-07-27T23:39:00Z,,0,0,0900006480bb0d1f